Close

Rating History for Nektar Therapeutics (NKTR) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/18/2022 Chris Shibutani Downgrade Sell
(Neutral)
3.00
(N/A)
6.16
(3.10)
-49.68% Details